Ignite Creation Date:
2024-07-17 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06489964
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-05-30
Brief Title:
Addressing Unfunded Vaccines Through a Co-payment Mechanism in Pharmacies
Sponsor:
Canadian Immunization Research Network
Organization:
Canadian Immunization Research Network
Study Overview
Official Title:
Addressing the Problem of Recommended But Unfunded Vaccines Through a Transitional Stepped Co-payment Mechanism in Pharmacies
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this pilot demonstration and evaluation project is to increase the accessibility and uptake of recommended immunizations in the general public by implementing a transitional stepped co-payment model in community pharmacies in Nova Scotia and Ontario for the delivery of recommended but unfunded vaccines until full public funding is available The main question it aims to answer is
Can a transitional stepped co-payment model through pharmacies for the delivery of recommended but unfunded vaccines eg Shingrix FluMist increase the accessibility and uptake of recommended immunizations among various stakeholders until full public funding is available
Participants will
Receive a reduced cost of the vaccine if eligible through this transitional stepped co-payment funding model as part of routine care following standard pharmacy practice
Complete a feedback and satisfaction survey exploring their thoughts on the transitional stepped co-payment model their satisfaction with the co-payment model their perception on vaccinations in general and specifically about recommended but unfunded vaccines and their demographics such as gender age education raceethnicity
Can a transitional stepped co-payment model through pharmacies for the delivery of recommended but unfunded vaccines eg Shingrix FluMist increase the accessibility and uptake of recommended immunizations among various stakeholders until full public funding is available
Participants will
Receive a reduced cost of the vaccine if eligible through this transitional stepped co-payment funding model as part of routine care following standard pharmacy practice
Complete a feedback and satisfaction survey exploring their thoughts on the transitional stepped co-payment model their satisfaction with the co-payment model their perception on vaccinations in general and specifically about recommended but unfunded vaccines and their demographics such as gender age education raceethnicity
Detailed Description:
While the National Advisory Committee on Immunization NACI provides vaccine recommendations it is the responsibility of provinces and territories in Canada to decide which vaccine programs they will support and implement publicly Some vaccines recommended by NACI are not publicly funded in Canada and require out-of-pocket pay or private health insurance plans This lack of public funding may be a factor contributing to low vaccine uptake Cost-related barriers are also important concerns among prescribers who tend to be hesitant in recommending vaccines that are not publicly funded due to issues with patient affordability Pharmacy professionals across Canada are increasingly taking a dominant role in administering certain publicly funded vaccines such as influenza and COVID-19 but administration of other publicly funded immunizations have been limited in many jurisdictions and pharmacy services providing unfunded vaccines are underutilized
Publicly funded immunization programs have demonstrated their cost-effectiveness for the healthcare system however evaluating the economic impact of introducing new vaccines into these programs is a time-consuming process resulting in delays in making them available for public funding The significant upfront costs of introducing a new vaccine program can be financially prohibitive acting as a major barrier to having vaccinations covered through public funding As a result introducing a co-payment system for recommended but unfunded vaccines may help mitigate the perception that these vaccines are of lesser importance especially if the government is covering a portion of the vaccine and administration fees A flexible transitional stepped co-payment model where the costs are shared between the patient or their private insurance and the government until full funding becomes available could potentially offer a solution to enhance immunization rates for these vaccines
In this Pilot Demonstration and Evaluation Project the investigators propose to better understand potential solutions to cost-related barriers that limit uptake of recommended but unfunded vaccines Implementation of a transitional stepped co-payment funding model within community pharmacies will be piloted at select community pharmacies in Nova Scotia and Ontario where pharmacists will prescribe and administer recommended but unfunded vaccines Electronic surveys will assess public and provider satisfaction with the model and vaccination rates before and after implementation will be compared
Publicly funded immunization programs have demonstrated their cost-effectiveness for the healthcare system however evaluating the economic impact of introducing new vaccines into these programs is a time-consuming process resulting in delays in making them available for public funding The significant upfront costs of introducing a new vaccine program can be financially prohibitive acting as a major barrier to having vaccinations covered through public funding As a result introducing a co-payment system for recommended but unfunded vaccines may help mitigate the perception that these vaccines are of lesser importance especially if the government is covering a portion of the vaccine and administration fees A flexible transitional stepped co-payment model where the costs are shared between the patient or their private insurance and the government until full funding becomes available could potentially offer a solution to enhance immunization rates for these vaccines
In this Pilot Demonstration and Evaluation Project the investigators propose to better understand potential solutions to cost-related barriers that limit uptake of recommended but unfunded vaccines Implementation of a transitional stepped co-payment funding model within community pharmacies will be piloted at select community pharmacies in Nova Scotia and Ontario where pharmacists will prescribe and administer recommended but unfunded vaccines Electronic surveys will assess public and provider satisfaction with the model and vaccination rates before and after implementation will be compared
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None